Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by pumpbuster2011

IMVIF

RE:RE:Curious

Would have had that news by now if it was coming today .. their standard is...

February 11, 2019

IMVIF

RE:RE:ever since hiring Mr. IR we have been...

The stock has turned into a bit of a joke at this point. The LOXO talk is...

February 10, 2019

IMVIF

RE:RE:RE:RE:Happy New Year

more tweeting from Thom -- any have access - unsure if any value to gleen...

January 9, 2019

IMVIF

RE:RE:RE:Happy New Year

if this is what Calandra was referencing as fresh patient data and catching...

January 8, 2019

IMVIF

Price Action

Seems we have yet another "Buy Rumour : Sell News" trend in the...

January 8, 2019

IMVIF

RE:NCIC Trials

i see nothing.. at all. Curious...

November 25, 2018

IMVIF

RE:RE:DPX-Survivac as Monotherapy For Recurring Ovarian Cancer

clinical marker present in apprx 30% of enrolled patients. Greater percentage...

November 20, 2018

T.PTG

conference call

Less confidence in this team than ever. Softball questions from Echelon. Who...

November 14, 2018

T.PTG

RE:i have emailed the company

Done. Expecting a canned response of no control over the market etc. Advised...

October 11, 2018

IMVIF

RE:RE:RE:RE:RE:RE:RE:Would love to see some updated news this week

I'm not sure i consider a $2.19 pre split stock pricing a thing of beauty...

October 11, 2018

T.PTG

RE:RE:Insider buy

$1.35 .. this stock is awesome!

October 5, 2018

IMVIF

RE:RE:IMV Inc. has 50 per cent upside, Mackie Research says

apprx 200k book value within 2 tfsa's -- have been acumulating shares...

September 14, 2018

IMVIF

RE:RE:RE:RE:RE:Sell on News

Either. Though they are in 30 day black-out for Q3 as of now. Will be until...

September 12, 2018

IMVIF

RE:RE:RE:Sell on News

time to keep a close eye on Insider movements ..

September 12, 2018

IMVIF

RE:RE:RE:RE: DPX-Survivac in Combination with KEYTRUDA® Across

Less than 1,700 shares traded an hour in on this news. Really shows the story...

September 11, 2018

IMVIF

RE:RE:RE: DPX-Survivac in Combination with KEYTRUDA® Across

"MORE" than 200 patients... huge news.  Market is tentative...

September 11, 2018

T.PTG

it continues

Off to a red start again today. No end in sight ..  Some sort of news or...

September 7, 2018

IMVIF

RE:RE:HCW Conference

ok great - was listening while multi-tasking so must have misheard...

September 7, 2018

IMVIF

HCW Conference

Any comments on the conference call today? Seems timelines getting gray...

September 6, 2018

T.PTG

RE:RE:RE:WTF?

thanks nini222 - greatly appreciate that insight and explanation. If more...

September 5, 2018

Prev 1 2 3 4 5 6 7 Next

Featured Company

Viva Gold Corp.

Viva Gold Corp. V.VAU

Viva Gold Corp. is a Canada-based gold exploration and development company, The Company’s business is the acquisition ... view more »